From: Clinical and economic impact of goal-directed fluid therapy during elective gastrointestinal surgery
 | GDFT (n = 201) | Traditional (n = 200) | p value |
---|---|---|---|
Sex (male/female, n) | 116/85 | 125/75 | 0.328 |
Age (mean ± SD, year) | 62.7 ± 12.2 | 62.2 ± 12.3 | 0.697 |
Height (mean ± SD, cm) | 161.1 ± 7.3 | 162.0 ± 7.5 | 0.243 |
Weight (mean ± SD, kg) | 57.1 ± 9.9 | 60.3 ± 10.9 | 0.002 |
ASA physical status (II/III/IV, n) | 140/58/3 | 154/44/2 | 0.248 |
Comorbidities | |||
 Coronary artery disease (yes/no, n) | 12/189 | 14/186 | 0.675 |
 Hypertension (yes/no, n) | 50/151 | 48/152 | 0.838 |
 Diabetes mellitus (yes/no, n) | 22/179 | 18/182 | 0.516 |
 Surgical type (gastric/small bowel/colonic/rectal, n) | 34//3/70/94 | 46/1/67/86 | 0.228 |
 Surgical approach (open/laparoscopic, n) | 23/178 | 21/179 | 0.763 |
 Arterial line inserted (yes/no, n) | 201/0 | 183/17 | < 0.001 |
 Surgical duration (median (IQR), min) | 219 (180–268) | 220 (180–260) | 0.327 |